Abstract:Background Delivery variations during radiotherapy can cause discrepancies between planned and delivered dose distribution. These variations could arise from random and systematic offsets in certain machine parameters or systematic offsets related to the calibration process of the treatment unit. Purpose The aim of this study was to present a novel simulation‐based methodology to evaluate realistic delivery variations in three dimensions (3D). Additionally, we investigated the dosimetric impact of delivery variations for volumetric modulated arc therapy (VMAT) plans for different treatment sites and complexities. Methods Twelve VMAT plans for different treatment sites (prostate‐, head & neck‐, lung‐, and gynecological cancer) were selected. The clinical plan used for the treatment of each patient was reoptimized to create one plan with reduced complexity (i.e., simple plan) and one of higher complexity (i.e., complex plan). This resulted in a total of 36 plans. Delivery variations were simulated by randomly introducing offsets in multi‐leaf collimator position, jaw position, gantry angle and collimator angle simultaneously. Twenty simulations were carried out for each of the 36 plans, yielding 720 simulated deliveries. To explore the impact of individual offsets, additional simulations were conducted for each type of offset separately. A 3D dose calculation was performed for each simulation using the same calculation engine as for the clinical plan. Two standard deviations (2SD) of dose were determined for every voxel for 3D‐spatial evaluations. The dose variation in certain DVH metrics, that is, D2% and D98% for the clinical target volume and five different DVH metrics for selected organs at risk, was calculated for the twenty simulated deliveries of each plan. For comparison, the effect of delivery variations was assessed by conducting measurements with the Delta4 phantom. Results The volume of voxels with 2SD above 1% of the prescribed dose was consistently larger for the complex plans in comparison to their corresponding simple and clinical plans. 2SDs larger than 1% were in many cases, found to accumulate outside the planning target volume. For complex plans, regions with 2SDs larger than 1% were detected also inside the high dose region, exhibiting, on average, a size six times larger volume, than those observed in simple plans. Similar results were found for all treatment sites. Variation in the selected DVH metrics for the simulated deliveries was generally largest for the complex plans with few exceptions. When comparing the 2SD distribution of the measurements with the 2SD distribution from the simulations, the spatial information showed deviations outside the PTV in both simulations and measurements. However, the measured values were, on average, 35% higher for the prostate plans and 10% higher for the head & neck plans compared to the simulated values. Conclusions The presented methodology effectively quantified and localized dose deviations due to delivery offsets. The 3D analysis provided information that was undetectable using the analysis based on DVH metrics. Dosimetric uncertainties due to delivery variations were prominent at the edge of the high‐dose region irrespective of treatment site and plan complexity. Dosimetric uncertainties inside the high‐dose region was more profound for plans of higher complexity.

Empirical Model for a Three-Dimensional Dose Verification System and Its Application in Volumetric-Modulated Arc Therapy for Heterogeneous and Long-Target Tumors

Volumetric and Dosimetric Variations in Radiation Treatment Planning Using CT Images Based on Different Reconstructed Field-of-view

Automated Clinical Target Volume Delineation Using Deep 3D Neural Networks in Radiation Therapy of Non-small Cell Lung Cancer

A method for selecting reference beam model of VMAT plans with three 6MV beam-matched linear accelerators during radiation oncology

Evaluation research of implementing intensity-modulated verification of individualization for patient based on various dosimetric tools

The Feasibility Study on the Generalization of Deep Learning Dose Prediction Model for Volumetric Modulated Arc Therapy of Cervical Cancer

Patient specific quality assurance of volumetric modulated arc therapy of synchronous bilateral breast cancer

Commissioning of Axesse Accelerator for Volumetric Modulated Arc Therapy

A Novel Approach for Position Verification and Dose Calculation through Local MVCT Reconstruction

Monte Carlo modeling of HD120 multileaf collimator on Varian TrueBeam linear accelerator for verification of 6X and 6X FFF VMAT SABR treatment plans

Impact of delivery variations on 3D dose distributions for volumetric modulated arc therapy plans of various complexity

Implementation of volumetric-modulated arc therapy for locally advanced breast cancer patients: Dosimetric comparison with deliverability consideration of planning techniques and predictions of patient-specific QA results via supervised machine learning

Influence of dose calculation algorithms on the helical diode array using volumetric‐modulated arc therapy for small targets

Preliminary Results on In-Vivo Dose Measurement of Intensity-Modulated Radiotherapy for Cervical Cancer

Investigation of the feasibility of using kilovoltage cone-beam CT for accuracy dose calculation in esophageal cancer radiotherapy

Dosimetric features‐driven machine learning model for DVH prediction in VMAT treatment planning

SU‐D‐BRA‐03: Simultaneous MV‐KV Imaging for Intra‐Fractional Motion Management During Volume Modulated Arc Therapy (VMAT) Delivery on the Varian TrueBeam

The dosimetric accuracy of a commercial model-based dose calculation algorithm in modeling a six-groove direction modulated brachytherapy tandem applicator

Investigation of a 3D dosimetry system utilizing radio-chromic gel and telecentric optical-CT readout

Multileaf Collimator Modeling and Commissioning for Complex Radiation Treatment Plans Using 2-Dimensional (2D) Diode Array MapCHECK2

Machine log file-based dose verification using novel iterative CBCT reconstruction algorithm in commercial software during volumetric modulated arc therapy for prostate cancer patients